PEGBIO CO-B (02565) completed the issuance of a total of 5.136 million shares for subscription.

20:59 22/12/2025

Peg Bio-pharma-B (02565) announced that all conditions of the placement agreement have been met, and the placement was completed on December 22, 2025. In accordance with the terms and conditions of the placement agreement, the joint placing agents have placed a total of 5,136,000 placement shares with no less than 6 placees at a price of HK$58.41 per share, representing approximately 1.81% of the H Shares issued and expanded after the completion of the placement, and approximately 1.31% of the total number of shares.

PEGBIO CO-B(02565) announcement, all conditions of the subscription agreement have been met, and the subscription was completed on December 22, 2025. According to the terms and conditions of the subscription agreement, the joint subscription agents have subscribed a total of 5.136 million shares to no fewer than 6 subscribers at a price of HK$58.41 per share, representing approximately 1.81% of the H shares outstanding after the completion of the subscription, and approximately 1.31% of the total number of shares.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"